Overall Survival (Os) in the Imelda Randomized Phase Iii Trial of Maintenance Bevacizumab (Bev) with or Without Capecitabine (Cap) for Her2-Negative Metastatic Breast Cancer (Mbc)
AuthID
P-00G-D2N
P-00G-D2N